| Literature DB >> 36147340 |
Zhihua Yang1,2, Shanshan Lin3, Wanying Feng1,2, Yangxi Liu3, Zhihui Song1,2, Guiyun Pan1,2, Yuhang Zhang1,2, Xiangdong Dai1,2, Xinya Ding3, Lu Chen1,2, Yi Wang1,2.
Abstract
Intestinal macrophages are the main participants of intestinal immune homeostasis and intestinal inflammation. Under different environmental stimuli, intestinal macrophages can be polarized into classical activated pro-inflammatory phenotype (M1) and alternative activated anti-inflammatory phenotype (M2). Its different polarization state is the "guide" to promoting the development and regression of inflammation. Under normal circumstances, intestinal macrophages can protect the intestine from inflammatory damage. However, under the influence of some genetic and environmental factors, the polarization imbalance of intestinal M1/M2 macrophages will lead to the imbalance in the regulation of intestinal inflammation and transform the physiological inflammatory response into pathological intestinal injury. In UC patients, the disorder of intestinal inflammation is closely related to the imbalance of intestinal M1/M2 macrophage polarization. Therefore, restoring the balance of M1/M2 macrophage polarization may be a potentially valuable therapeutic strategy for UC. Evidence has shown that traditional Chinese medicine (TCM) has positive therapeutic effects on UC by restoring the balance of M1/M2 macrophage polarization. This review summarizes the clinical evidence of TCM for UC, the vital role of macrophage polarization in the pathophysiology of UC, and the potential mechanism of TCM regulating macrophage polarization in the treatment of UC. We hope this review may provide some new enlightenment for the clinical treatment, fundamental research, and research and development of new Chinese medicine of UC.Entities:
Keywords: gut microbiota; macrophage polarization; potential mechanisms; signaling pathway; traditional Chinese medicine; ulcerative colitis
Year: 2022 PMID: 36147340 PMCID: PMC9486102 DOI: 10.3389/fphar.2022.999179
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1Overview of different biological and physiological features of macrophages polarization.
TCM compound alleviates UC by regulating macrophage polarization.
| TCM compound | Cellular or animal models | Main findings | Mechanism | Refer |
|---|---|---|---|---|
| Baitouweng decoction | DSS-induced colitis in mice | 1) Improved colon shortening, reversed loss of body weight, decreased DAI scores | 1) IL-1β↓, IL-6↓, TNF-α↓ |
|
| 2) Ameliorated colonic pathological damage | 2) Attenuated DSS-induced colitis by suppressing the activation of the IL-6/STAT3 signaling pathway | |||
| 3)Inhibited M1 macrophage polarization | ||||
| Shenling Baizhu San | DSS-induced colitis in mice, TNFα-treated RAW 264.7 cell | 1) Rescue colitis- caused epithelial deconstruction and weight loss | 1) CXCL1↓, IL-17↓, ROS↓ |
|
| 2) Improved colonic pathological damage | 2) Rescued TNFα-induced pyroptosis of intestinal organoids | |||
| — | 3) Suppressed macrophage transition to pro-inflammatory phenotype (M1) | |||
| — | 4) Decreased the recruitment of macrophage by epithelial cells | |||
| Wumeiwan | DSS-induced colitis in mice | 1) Improve inflammatory cell infiltration and crypt injury in the colonic tissues of colitis mice | 1)IL-10↑, TGF-β↑, Arg1↑, TNF-α↓, IL-1↓, IL-1β↓, IL-6↓, IRF5↓ |
|
| 2) Decreased histopathological scores | 2)Decrease macrophage infiltration and activation | |||
| 3) Decreased DAI scores and alleviated colon shortening | 3)Inhibited M1 macrophage polarization and promoted M2 macrophage polarization | |||
| Gegen Qinlian decoction | DSS-induced colitis in mice | 1) Ameliorated colon shortening, reversed loss of body weight, decreased DAI scores | 1) IL-10↑, IL-1β↓, IL-6↓, TNF-α↓ |
|
| 2) Improved colon tissue injury | 2) Decrease the percentage of M1 macrophages and increase the percentage of M2 macrophages | |||
| 3) Alleviated the histopathologic damage | ||||
| Banxia Xiexin decoction | TNBS-induced colitis in rats | 1) Decreased DAI scores and colon weight index | 1) IL-4↑, IL-10↑, SOD↑, 8-Oxoguanine↑, Nrf2↑, IL-1β↓, IL-6↓, TNF-α↓, IL-17↓, IL-23↓, COX-2↓, p-p65↓, MDA↓, MPO↓, 8-Oxoguanine↓ |
|
| 2) Alleviated the histopathologic damage | 2) Possessed the potential of anti-inflammation and anti-oxidation |
| ||
| Guchangzhixie capsule | DSS-induced colitis in mice | 1)Relieved the epithelial structural collapse | 1) CXCL1↓, IL-17↓, ROS↓ |
|
| 2)Alleviated the severity of fecal blood and albumin, shortened colon length | 2) Restored bacterial diversity of UC mice | |||
| — | 3) Suppressed macrophage transition to proinflammatory phenotype | |||
| Xian-He-Cao-Chang-Yan formula | DSS-induced colitis in mice, TNFα-treated RAW 264.7 cell | 1) Decreased DAI scores, attenuated the colon shortening | 1)Suppressed the M1 polarization of macrophages and increased the M2 polarization of macrophages |
|
| 2) Alleviated the histopathologic damage | 2)Regulated energy metabolism in macrophages through AMPK | |||
| 3) Reduced the levels of HK2 and lactic acid | — |
TCM ingredient alleviates UC by regulating macrophage polarization.
| TCM ingredient | Source | Cellular or animal models | Main findings | Mechanism | Refer |
|---|---|---|---|---|---|
| Acacetin | Acacia honey and citrus fruits | DSS-induced colitis in mice, LPS-treated RAW 264.7 cells | 1) Ameliorated body weight loss, diarrhea, colon shortening | 1) IL-1β↓, IL-6↓, TNF-α↓, NO↓, iNOS↓, COX-2↓ |
|
| 2) Alleviated the loss of mucosal architecture, ulcerations, and inflammatory infiltration | 2) Attenuated DSS-induced colitis in mice by inhibiting inflammation and regulating the intestinal microbiota | ||||
| 3) Decreased macrophage infiltration and the levels of inflammatory mediators | — | ||||
| Asperuloside |
| DSS-induced colitis in mice, LPS-treated RAW 264.7 cells | 1) Improved weight loss, shortening of the colon length, and colon thickness, decreased DAI scores | 1)IL-10↑, SOD ↑, GSH-Px↑, Nrf2↑, HO-1↑,NQO-1↑, MDA↓, TNF-α↓, IL-6↓, p65↓, ROS↓ |
|
| 2) Remarkably decreased the MPO activity | 2) Improved DSS-induced chronic colitis by alleviating inflammation and oxidative stress | ||||
| 3) Ameliorated colonic pathological damage | — | ||||
| Astragaloside IV |
| DSS-induced colitis in mice | 1) Alleviated body weight loss and the reduction in colon length, decreased cumulative DAI scores | 1) IL-10↑, TGF-β↑, p-STAT3↑, TNF-α↓, IL-1β↓, iNOS↓, p-STAT1↓ |
|
| 2) Reduced MPO activity | 2) Suppressed pro-inflammatory macrophage subsets and promoted pro-resolving macrophage subsets | ||||
| 3) Decreased histopathological scores | 3) Modulated macrophage polarization by remodeling the STAT signaling | ||||
| Berberine |
| DSS-induced colitis in mice | 1) Ameliorated DSS-induced colon shortening | 1) AKT1↑, SOCS1↑, p-p65↓, IL-1β↓, IL-6↓, IL-12↓, TNF-α↓, iNOS↓, NO↓ |
|
| 2) Improved colon tissue injury | 2) Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway | ||||
| 3) Significant reduction in the DAI scores | — | ||||
| Berberine |
| DSS-induced colitis in mice | 1) Alleviated body weight loss | 1) IL-10↑, TGF-β↑, Arg1↑, TNF-α↓, IL-6↓, iNOS↓, p50↓, p65↓ |
|
| 2) Improved colonic pathological damage | 2) Inhibited M1 macrophages polarization, promoted M2 macrophages polarization, improved the intestinal inflammatory environment, and relieved colitis by inhibiting NF-κB signaling pathway | ||||
| Curcumin |
| DSS-induced colitis in mice | 1) Improved the body weight, colon weight and length, colonic weight index | 1) IL-33↑, IL-10↑, IL-1β↓, IL-6↓, CCL-2↓, TLR2↓, TLR4↓, MyD88↓, NF-κBp65↓, p38MAPK↓, AP-1↓ |
|
| 2) Significantly downregulated the pathological damage scores | 2) Exerted therapeutic effects in colitis mice by regulating the balance of M1/M2 macrophage polarization and TLRs signaling pathway | ||||
| Polysaccharide from Dictyophora indusiata |
| DSS-induced colitis in mice | 1) Reduced DAI scores and MPO activity, relieved splenomegaly | 1) GSH↑, HO-1↑, Bcl2↑, MDA↓, TNF-α↓, IL-1β↓, IL-6↓, IL-18↓, NLRP3↓, p-STAT3↓, p-IκBα↓ |
|
| 2) Alleviated the histopathologic damage, including ameliorated disrupted tissue architecture, inflammatory infiltration, hyperemia and the disappearance of intestinal crypts and goblet cells | 2) Inhibited DSS-induced apoptosis and deletion of tight junction protein in colonic tissues | ||||
| — | 3) Alleviated DSS-induced colitis via regulating macrophage subset | ||||
| Didymin | Fruits of rue family, such as oranges, lemons, and bergamot | DSS-induced colitis in mice | 1) Remarkedly decreased the DAI scores, alleviated colon shortening | 1) Arg1↑, IL-10↑, Chil3↑, Retnla↑, TNF-α↓, IL-1↓, IL-6↓, Nos2↓ |
|
| 2) Inhibited MPO activity, reduced neutrophils infiltration and improved histological damage | 2) Decreased the proportion of M1 macrophages and comparatively increased the number of macrophages, and induced M1- to M2-like macrophage conversion | ||||
| Dioscin |
| DSS-induced colitis in mice, INF-γ/LPS-treated RAW 264.7 cells | 1) Reversed loss of body weight, decreased DAI scores, extended colon length | 1) IL-10↑, TNF-α↓, IFN-γ↓, and IL-6↓, iNOS↓, IL-1β↓, NO↓ |
|
| 2) Inhibited the infiltration of inflammatory cells, and relieved damage to the colonic mucosa | 2) Reduced M1 macrophage polarization and facilitated transition of RAW264.7 cells towards M2 Phenotype | ||||
| — | 3) Protected mice against DSS-induced UC by regulating mTOR signaling, thereby adjusting macrophage metabolism and polarization | ||||
| Gentiopicroside |
| DSS-induced colitis in mice | 1) Increased the body weight and colon length, decreased colon weight and colonic weight index | 1) IL-4↑, IL-10↑, CD206↑, IL-6↓, IL-12↓, iNOS↓, p-JAK2/JAK2↓, p-STAT3/STAT↓ |
|
| 2) Decresed DAI scores | 2) Down-regulated the phosphorylation of the JAK2/STAT3 pathway | ||||
| 3) Improved histopathological damage | 3) Regulated the polarization of colonic macrophages towards M2 macrophages | ||||
| Ginsenoside Rg1 |
| DSS-induced colitis in mice | 1)Improved mouse body weight, mouse final weight, colonic weight, colonic length, colonic weight index | 1) IL-4↑, IL-10↑, Arg1↑, IL-6↓, IL-33↓, CCL-2↓, TNF-α↓, Rock1↓, RhoA↓, Nogo-B↓, MIF-1↓, PIM-1 |
|
| 2) Ameliorated pathological damage | 2) Ameliorated colitis by regulating M1/M2macrophage polarization and microbiota composition | ||||
| 3) Improved the diversity of colonic microbiota | 3) Inhibited the activation of Nogo-B/RhoA signalling pathway | ||||
| Loganin |
| DSS-induced colitis in mice | 1) Decreased body weight loss, colon shortening, and DAI scores | 1) IL-1β↓, IL-6↓, TNF-α↓, MCP-1↓, CXCL10↓, COX-2↓ |
|
| 2) Reduced myeloperoxidase (MPO) activity and ameliorated pathologic abnormalities | 2) Remarkably reduced macrophage M1 polarization | ||||
| — | 3) Inhibited M1 macrophage-mediated inflammation | ||||
| Lupeol | Vegetables, fruits, medicinal plants | DSS-induced colitis in mice | 1) Mitigated intestinal inflammation and improved survival from lethal colitis | 1) IL-10↑, IGF-1↑, Arg-1↑, CD206↑, IL-12↓, IL6↓, IL-1β↓, TNFα↓, iNOS↓, CD86↓, p38↓ |
|
| 2) Reduced histological score | 2) Ameliorated mitigated intestinal inflammation through inhibiting M1 and promoting M2 macrophages | ||||
| Platycodin D |
| DSS-induced colitis in mice | 1) Improved the weight loss, colon shortening, and reduced DAI scores | 1) IL-10↑, Arg1↑, TNF-α↓, IL-6↓, IL-1β↓, iNOS↓ |
|
| 2) Alleviated colonic pathological damage | 2) Inhibited the M1 macrophage polarization and promoted the M2 macrophage polarization | ||||
| 3) Inhibited the levels of inflammation in peripheral and colon tissues | 3)Protected intestinal barrier function and improved intestinal inflammation by regulating macrophage polarization via activating AMPK | ||||
| Punicalagin |
| LPS-induced RAW264.7 cells | 1) Reduced LPS-Induced NO and PGE2 production | 1) IL-1β↓, IL-6↓, TNF-α↓ TLR4↓, phosphorylation of IκBα↓ |
|
| 2) Inhibited LPS-Induced iNOS and COX-2 expression | 2) Inhibited LPS-induced inflammation via the suppression of TLR4-Mediated MAPKs and NF-κB Activation | ||||
| Rosmarinic acid |
| DSS-induced colitis in mice, INF-γ/LPS-treated RAW 264.7 cells | 1) Improved the weight loss, diarrhea, and hematochezia | 1) Arg1↑, Mrc2↑, Dectin-1↑, TNF-α↓, IL-1β↓, NOS2↓, CCL4↓, IL-12↓ |
|
| 2) Alleviated colonic pathological damage | 2) Improved UC by regulating macrophage polarity | ||||
| — | 3) Restricted macrophage polarization toward M1 depending on the inhibition of NF-κB p65 nuclear translocation by increasing HO-1 | ||||
| Safranal |
| DSS-induced colitis in mice, LPS-treated RAW 264.7 cells | 1) Alleviated the clinical symptoms, decreased DAI scores | 1) IL-6↓, TNF-α↓, NO↓, iNOS↓, COX-2↓ |
|
| 2) Decreased the severity of colon tissues inflammation, depth of inflammatory involvement, and crypt damage | 2) Inhibited the phosphorylation of proteins ERK, JNK, and p38 | ||||
| 3) Reduced the amount of macrophages accumulated in colonic tissue, mesenteric lymph nodes and spleens | 3) Suppressed the phosphorylation and nuclear translocation of components of the MAPK and NF-κB pathways | ||||
| Tiliroside | Several edible plants or specific plant parts (fruits, leaves, or roots) | DSS-induced colitis in mice | 1)Increased survival rate, decreased DAI scores, longer colon length | 1) Arg1↑, Chil3↑, Cd206↑, IL-1β↓, iNOS↓, TNF-α↓ |
|
| 2)Reduced MPO activity | 2) Promoted M2 macrophage polarization and inhibited M1 macrophage polarization | ||||
| 3)Ameliorated pathological changes of colons | 3) Regulated macrophage polarization via blocking glycolysis pathway | ||||
| Toosendanin |
| DSS-induced colitis in mice | 1) Alleviated body weight loss, reduced DAI scores and the spleen weight | 1) SOD↑, GSH↑, TNF-α↓, IL-1β↓, IL-6↓, MDA↓ |
|
| 2) Reduced colonic tissue damage and tremendously increased MPO activity | 2) Decreased the ratio of M1 macrophages and promoted that of M2 macrophages | ||||
| 3) Suppressed the activation of NLRP3 inflammasome and promoted the Nrf2/HO-1 signaling | |||||
| Total flavonoids of |
| LPS-induced RAW264.7 cells | 1) Inhibited the LPS-induced inflammatory response | 1) IL-1β↓, IL-6↓, TNF-α↓, iNOS↓, NO↓ |
|
| 2) Exerted anti-inflammatory activity via suppression of the NF-κB and MAPK signaling pathways | |||||
| Vitexin | Several traditional Chinese medical herbs | AOM/DSS-induced colorectal cancer in mice | 1) Attenuated colitis signs, colonic injury | 1) IL-10↑, IL-1β↓, IL-6↓, TNF-α↓ |
|
| 2) Decreased M1 phenotype macrophages in the adjacent noncancerous tissue |
FIGURE 2The role of intestinal macrophage polarization in the pathogenesis of UC and the potential mechanisms of TCM for UC based on intestinal macrophage polarization. When intestinal inflammation occurs in patients with UC, the lamina propria of the intestinal mucosa recruit a large number of monocytes and differentiate into immature M0 macrophages. Induced by a large number of pro-inflammatory factors (IFNγ, LPS, TNF-α), macrophages polarize toward the M1 phenotype and secrete a large number of pro-inflammatory cytokines, chemokines, and inflammatory mediators, causing an imbalance in the regulation of intestinal inflammation, transforming the physiological inflammatory response into pathological intestinal injury and aggravating the condition of UC. In addition, M1 macrophages can further aggravate the intestinal injury by secreting IL-12, IL-23, IL-1β and increasing Th1/Th17 activity. In the treatment stage, TCM can promote M2 macrophage polarization and inhibit M1 macrophage polarization by regulating the signaling pathways related to macrophage polarization, regulating gut microbiota and its metabolites, thus reducing the intestinal inflammatory response, promoting intestinal tissue repair, and alleviating UC progression.